Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))

Zhiyuan Liu; Yongyong Hou; Lu Li; Yang Yang; Jingkun Jia; Zhixuan Hong; Tingfeng Li; Yuanyuan Xu; Jingqi Fu; Yongxin Sun; Masayuki Yamamoto; Huihui Wang; Jingbo Pi

doi:10.1016/j.taap.2021.115801

Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))

Zhiyuan Liu, Yongyong Hou, Lu Li, Yang Yang, Jingkun Jia, Zhixuan Hong, Tingfeng Li, Yuanyuan Xu, Jingqi Fu, Yongxin Sun, Masayuki Yamamoto, Huihui Wang, Jingbo Pi

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

The original version of this article contained an error in Fig. 5A. A representative figure of the NAC group was accidentally put into the NAC + iAs group in Nrf2-KD cells during the figure preparation stage. The error has been corrected in this version. The authors regret this error. (See Fig. 5.)

Original language	English
Article number	115801
Journal	Toxicology and Applied Pharmacology
Volume	435
DOIs	https://doi.org/10.1016/j.taap.2021.115801
Publication status	Published - 2022 Jan 15
Externally published	Yes

ASJC Scopus subject areas

Toxicology
Pharmacology

Access to Document

10.1016/j.taap.2021.115801

Fingerprint

Dive into the research topics of 'Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))'. Together they form a unique fingerprint.

Cite this

Liu, Z., Hou, Y., Li, L., Yang, Y., Jia, J., Hong, Z., Li, T., Xu, Y., Fu, J., Sun, Y., Yamamoto, M., Wang, H., & Pi, J. (2022). Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003)). Toxicology and Applied Pharmacology, 435, [115801]. https://doi.org/10.1016/j.taap.2021.115801

Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003)). / Liu, Zhiyuan; Hou, Yongyong; Li, Lu et al.

In: Toxicology and Applied Pharmacology, Vol. 435, 115801, 15.01.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Liu, Z, Hou, Y, Li, L, Yang, Y, Jia, J, Hong, Z, Li, T, Xu, Y, Fu, J, Sun, Y, Yamamoto, M, Wang, H & Pi, J 2022, 'Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))', Toxicology and Applied Pharmacology, vol. 435, 115801. https://doi.org/10.1016/j.taap.2021.115801

Liu Z, Hou Y, Li L, Yang Y, Jia J, Hong Z et al. Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003)). Toxicology and Applied Pharmacology. 2022 Jan 15;435:115801. doi: 10.1016/j.taap.2021.115801

Liu, Zhiyuan ; Hou, Yongyong ; Li, Lu et al. / Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003)). In: Toxicology and Applied Pharmacology. 2022 ; Vol. 435.

@article{23a707eee0b1439da770afe72d022053,

title = "Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))",

abstract = "The original version of this article contained an error in Fig. 5A. A representative figure of the NAC group was accidentally put into the NAC + iAs group in Nrf2-KD cells during the figure preparation stage. The error has been corrected in this version. The authors regret this error. (See Fig. 5.)",

author = "Zhiyuan Liu and Yongyong Hou and Lu Li and Yang Yang and Jingkun Jia and Zhixuan Hong and Tingfeng Li and Yuanyuan Xu and Jingqi Fu and Yongxin Sun and Masayuki Yamamoto and Huihui Wang and Jingbo Pi",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2022",

month = jan,

day = "15",

doi = "10.1016/j.taap.2021.115801",

language = "English",

volume = "435",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))

AU - Liu, Zhiyuan

AU - Hou, Yongyong

AU - Li, Lu

AU - Yang, Yang

AU - Jia, Jingkun

AU - Hong, Zhixuan

AU - Li, Tingfeng

AU - Xu, Yuanyuan

AU - Fu, Jingqi

AU - Sun, Yongxin

AU - Yamamoto, Masayuki

AU - Wang, Huihui

AU - Pi, Jingbo

PY - 2022/1/15

Y1 - 2022/1/15

N2 - The original version of this article contained an error in Fig. 5A. A representative figure of the NAC group was accidentally put into the NAC + iAs group in Nrf2-KD cells during the figure preparation stage. The error has been corrected in this version. The authors regret this error. (See Fig. 5.)

AB - The original version of this article contained an error in Fig. 5A. A representative figure of the NAC group was accidentally put into the NAC + iAs group in Nrf2-KD cells during the figure preparation stage. The error has been corrected in this version. The authors regret this error. (See Fig. 5.)

UR - http://www.scopus.com/inward/record.url?scp=85119909808&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85119909808&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2021.115801

DO - 10.1016/j.taap.2021.115801

M3 - Comment/debate

C2 - 34798141

AN - SCOPUS:85119909808

SN - 0041-008X

VL - 435

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

M1 - 115801

ER -

Corrigendum to “Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic” [Toxicology and applied pharmacology 367 (2019) 62–70] (Toxicology and Applied Pharmacology (2019) 367 (62–70), (S0041008X19300523), (10.1016/j.taap.2019.02.003))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this